Recent Patents on Inflammation & Allergy Drug Discovery
Title:ACKNOWLEDGEMENTS TO CONTRIBUTORS
Volume: 11 Issue: 2
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, ACKNOWLEDGEMENTS TO CONTRIBUTORS, Recent Patents on Inflammation & Allergy Drug Discovery 2017; 11 (2) . https://dx.doi.org/10.2174/1872213X1102171222164342
DOI https://dx.doi.org/10.2174/1872213X1102171222164342 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
18
Related Articles
-
Endostatin: Preclinical Development as an Anticancer Agent
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Anti-Proliferative, Anti-Inflammatory, Anti-Ulcerogenic and Wound Healing Properties of Chitosan
Current Bioactive Compounds Longevity Depends on a Balance Between Proinflammatory and Anti-Inflammatory Factors: Use of Tcms and Natural Products
Current Drug Discovery Technologies Mechanistic Overview of Immune Modulatory Effects of Environmental Toxicants
Inflammation & Allergy - Drug Targets (Discontinued) Advances in Long-Circulating Drug Delivery Strategy
Current Drug Metabolism The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators
CNS & Neurological Disorders - Drug Targets Clonetics
Current Drug Metabolism Immunomodulatory Actions of Vitamin D Metabolites and their Potential Relevance to Human Lung Disease
Current Respiratory Medicine Reviews Pregnancy Associated Brucellosis
Recent Patents on Anti-Infective Drug Discovery Renoprotection by Direct Renin Inhibition: A Review Article and Meta-Analysis
Current Vascular Pharmacology Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
Current Medicinal Chemistry Targeted Lipid Nanoparticles for Antisense Oligonucleotide Delivery
Current Pharmaceutical Biotechnology Role of Leptin in the Immune System
Current Immunology Reviews (Discontinued) Asthma, Allergy and Chemokines
Current Drug Targets Squalene as Novel Food Factor
Current Pharmaceutical Biotechnology Anticipation in Lynch Syndrome: Where We Are Where We Go
Current Genomics The Bioartificial Kidney in the Treatment of Acute Kidney Injury
Current Drug Targets Resting State Abnormalities in Psychosis Compared to Acute Cannabinoids and Opioids Challenges: A Systematic Review of Functional Imaging Studies
Current Pharmaceutical Design Novel Drug Targets for the Treatment of Cardiac Diseases
Current Pharmacogenomics and Personalized Medicine Neuropeptides and Other Chemical Mediators, and the Role of Anti-inflammatory Drugs in Primary Headaches
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry